Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986;89(3):265-8.
doi: 10.1007/BF00174356.

Involvement of different dopamine receptors in rat diphasic motility response to apomorphine

Comparative Study

Involvement of different dopamine receptors in rat diphasic motility response to apomorphine

A Vaccheri et al. Psychopharmacology (Berl). 1986.

Abstract

A critical dose of apomorphine (300 micrograms/kg SC) given immediately before placing rats into a novel environment produced a diphasic motility response (initial sedation followed by enhanced locomotion). Various neuroleptics having different clinical and/or pharmacological profiles were studied by using such a model. (-)-Sulpiride and sultopride preferentially antagonized apomorphine inhibition; haloperidol and tiapride antagonized both phases of apomorphine response at similar doses; chlorpromazine, fluphenazine, thioridazine, metoclopramide and SCH 23390 preferentially antagonized apomorphine stimulation. The results are discussed in terms of the dopamine receptor subtypes involved in the two phases of apomorphine effect. Apomorphine stimulation can be antagonized by D-1 as well as D-2 receptor blockade. A higher affinity for D-2 receptors seems a necessary requisite for the antagonism of apomorphine inhibition; moreover, the ability of neuroleptics to antagonize apomorphine inhibition seems to depend on the ratio of their presynaptic versus postsynaptic D-2 activity.

PubMed Disclaimer

References

    1. Psychopharmacologia. 1973;29(4):289-98 - PubMed
    1. Psychopharmacology (Berl). 1984;82(4):409-10 - PubMed
    1. J Pharm Pharmacol. 1983 Jun;35(6):363-8 - PubMed
    1. Life Sci. 1985 May 13;36(19):1857-64 - PubMed
    1. Psychopharmacology (Berl). 1983;81(3):214-9 - PubMed

Publication types

LinkOut - more resources